FIELD: medicine.
SUBSTANCE: invention relates to a method for the differential diagnosis of post-traumatic and idiopathic epilepsy, which consists in determining the concentration of neuregulin-1 in blood serum and when its value is from 0 to 0.035 ng/ml idiopathic epilepsy is diagnosed, when the index value is higher than 0.035 ng/ml, post-traumatic epilepsy is diagnosed.
EFFECT: development of an accessible, accurate, objective method for the differential diagnosis of post-traumatic and idiopathic epilepsy through the use of reliable laboratory criteria.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF INDIVIDUAL RISK OF DEVELOPING POST-TRAUMATIC EPILEPSY | 2019 |
|
RU2725132C1 |
| ANTICONVULSANT AND ANTIHYPOXIC AGENT | 2008 |
|
RU2393857C2 |
| TREATMENT USING ESLICARBAZEPINE ACETATE OR ESLICARBAZEPINE | 2012 |
|
RU2639120C2 |
| METHOD FOR PREDICTING THE UNFAVORABLE COURSE OF EPILEPSY IN CHILDREN IN THE FIRST YEAR OF LIFE | 2022 |
|
RU2787512C1 |
| METHOD OF TREATING EPILEPSIAS | 2013 |
|
RU2548712C2 |
| METHOD FOR DETERMINING DEGREE OF PERSISTENT DISABILITY IN PATIENTS WITH POSTTRAUMATIC EPILEPSY | 2014 |
|
RU2572781C1 |
| METHOD OF ESTIMATING SEVERITY DEGREE OF EPILEPSY COMPLICATED BY ORGANIC ENCELOPHATHY | 2009 |
|
RU2433784C2 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF CONCUSSION AND INJURY OF BRAIN | 2010 |
|
RU2440581C1 |
| METHOD FOR DIAGNOSING NEUROIMMUNE DISORDERS IN YOUNG CHILDREN WITH EPILEPSY | 2021 |
|
RU2767271C1 |
| METHOD FOR PREDICTING MENTAL DISORDERS DEVELOPMENT IN SECONDARY BILATERAL SYNCHRONIZATION PHENOMENON BEING FORMED IN CHILDREN SUFFERING FROM EPILEPSY WITH TEMPORAL AND FRONTAL LOCALIZATION OF PRIMARY EPILEPSY FOCUS | 2005 |
|
RU2314749C2 |
